Your AI-Trained Oncology Knowledge Connection!

Mattea Reinisch

Articles by Mattea Reinisch

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE

BySherene Loi, MD, PhD,Erica Stringer-Reasor,Jean-Sebastien Frenel,Mattea Reinisch,Ruth M. O’Regan,Michelino De Laurentiis,Yeon Hee Park,Anne O’Dea,Yen-Shen Lu,Valeria Gonzalez,Melissa Gao,Sorcha Waters,Huilin Hu,Binghe Xu

June 24th 2025

Latest Updated Articles

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE
Published: June 24th 2025 | Updated:

Trending on CancerNetwork

How Will RLTs Be Integrated Into the Prostate Cancer Treatment Paradigm?

What Direction Should Marginal Zone Lymphoma Research Be Heading?

Two-Fraction SBRT Shows Acceptable Toxicity in Prostate Cancer Population

Progastrin-Releasing Peptide Levels Correlate With OS and PFS in LS-SCLC

Prognosis Strategy Exhibits Similar Transplant Outcomes in Select Patients

© 2025 MJH Life Sciences^®

All rights reserved.